Search

Your search keyword '"Quintana, Elsa"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Quintana, Elsa" Remove constraint Author: "Quintana, Elsa"
171 results on '"Quintana, Elsa"'

Search Results

2. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

3. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

4. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

5. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity

7. Supplementary Table S8 from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

8. Supplementary Figure S1-S6 from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

9. Supplementary Method from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

10. Data from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

11. Combining RASG12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold tumours hot

12. Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

14. Abstract LB015: Bi-steric mTORC1-selective inhibitors activate 4EBP1, suppress MYC, restore anti-tumor immunity, and cooperate with immune checkpoint inhibition to elicit tumor regression

15. Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

16. Abstract 3475: RMC-9805, a first-in-class, mutant-selective, covalent and orally bioavailable KRASG12D(ON) inhibitor, promotes cancer-associated neoantigen recognition and synergizes with immunotherapy in preclinical models

18. Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor

23. Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut

25. Abstract LB050: Modulation of innate and adaptive immunity in blood and tumor of patients receiving the SHP2 inhibitor RMC-4630

26. Abstract 1273: Discovery of a potent, selective, and orally bioavailable SOS1 inhibitor, RMC-023, an in vivo tool compound that blocks RAS activation via disruption of the RAS-SOS1 interaction

29. Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying

31. List of Contributing Authors

32. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity

33. Abstract 2837: Dual inhibition of SHP2 and CDK4/6 leads to immunological memory and immune-mediated anti-tumor activity in a mouse syngeneic model of breast cancer

34. Allosteric Inhibition of SHP2 Stimulates Antitumor Immunity by Transforming the Immunosuppressive Environment

38. Abstract A103: Allosteric inhibition of SHP2 induces antitumor immunity in PD-1-sensitive tumors through modulation of both innate and adaptive mechanisms

40. Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma

44. Orientaciones Didácticas y Guía de Recursos del Area de Música

45. Cuadernos para la coeducación 9. Música, Educación Plástica y Visual. Etapa Secundaria

Catalog

Books, media, physical & digital resources